These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 4116604)

  • 1. Plasma-corticosteroid determinations for assessment of pituitary response to metyrapone.
    Nattrass M; Smith J; Wood PJ; Marks V
    Lancet; 1972 Oct; 2(7783):903-4. PubMed ID: 4116604
    [No Abstract]   [Full Text] [Related]  

  • 2. Plasma corticosteroid response to metyrapone. A simplified assessment of pituitary-adrenal function.
    Jorgensen H; Aakvaag A
    Acta Med Scand; 1973 Jun; 193(6):537-42. PubMed ID: 4721962
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of diphenylhydantoin on the metabolism of metyrapone and release of ACTH in man.
    Meikle AW; Jubiz W; Matsukura S; West CD; Tyler FH
    J Clin Endocrinol Metab; 1969 Dec; 29(12):1553-8. PubMed ID: 4310497
    [No Abstract]   [Full Text] [Related]  

  • 4. DOSE RESPONSE CHARACTERISTICS OF METHOPIRAPONE: STUDIES IN DOGS UTILIZING A FLUORESCENCE PROCEDURE FOR ESTIMATING ADRENAL OUTPUT OF 11-HYDROXYCORTICOSTEROIDS.
    STEENBURG RW; THOMASSON BH
    Metabolism; 1965 Mar; 14():253-63. PubMed ID: 14261410
    [No Abstract]   [Full Text] [Related]  

  • 5. Plasma metyrapone, adrenocorticotropic hormone, cortisol, and deoxycortisol levels. Sequential changes during oral and intravenous metyrapone administration.
    Jubiz W; Matsukura S; Meikle AW; Harada G; West CD; Tyler FH
    Arch Intern Med; 1970 Mar; 125(3):468-71. PubMed ID: 4313727
    [No Abstract]   [Full Text] [Related]  

  • 6. The impaired response to metyrapone in patients taking oestrogen.
    Sprunt JG; Rutherford ER; Nelson DH
    Acta Endocrinol (Copenh); 1968 Nov; 59(3):447-53. PubMed ID: 4301815
    [No Abstract]   [Full Text] [Related]  

  • 7. Estimation of ACTH reserve on normal and hypopituitary subjects: comparison of oral and intravenous metyrapone with insulin hypoglycemia.
    Keenan BS; Beitins IZ; Lee PA; Kowarski A; Blizzard RM; Migeon CJ
    J Clin Endocrinol Metab; 1973 Oct; 37(4):540-9. PubMed ID: 4355091
    [No Abstract]   [Full Text] [Related]  

  • 8. Altered pathways of urinary corticosteroid excretion in liver disease studied by a clinical laboratory method.
    Bacchus H
    Clin Chem; 1969 Mar; 15(3):237-47. PubMed ID: 4304287
    [No Abstract]   [Full Text] [Related]  

  • 9. [ACTH response to 24 hours oral metyrapone test in normal children (author's transl)].
    Delepine N; Desbois JC; Techenet J; Gueris J; Herrault A
    Sem Hop; 1980 May 18-25; 56(19-20):946-50. PubMed ID: 6251560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-dose metyrapone test.
    Jubiz W; Meikle AW; West CD; Tyler FH
    Arch Intern Med; 1970 Mar; 125(3):472-4. PubMed ID: 4313728
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effects of metyrapone on plasma deoxycorticosterone and cortisol in children with idiopathic pituitary insufficiency].
    Szöts F; Lelièvre M; Tremblay RR
    Union Med Can; 1974 Mar; 103(3):448-52. PubMed ID: 4820872
    [No Abstract]   [Full Text] [Related]  

  • 12. A phenylalanine-lysine-vasopressin test of ACTH release.
    Strott CA; Nakagawa K; Nankin H; Nugent CA
    J Clin Endocrinol Metab; 1967 Mar; 27(3):448-51. PubMed ID: 4290323
    [No Abstract]   [Full Text] [Related]  

  • 13. Absorption and conjugation of metyrapone during diphenylhydantoin therapy: mechanism of the abnormal response to oral metyrapone.
    Jubiz W; Levinson RA; Meikle AW; West CD; Tyler FH
    Endocrinology; 1970 Feb; 86(2):328-31. PubMed ID: 4311903
    [No Abstract]   [Full Text] [Related]  

  • 14. [A study on adrenocortical function test in pregnant women].
    Higuchi M
    Nihon Sanka Fujinka Gakkai Zasshi; 1972 May; 24(5):345-54. PubMed ID: 4340287
    [No Abstract]   [Full Text] [Related]  

  • 15. A cause of apparently abnormal urinary 17-hydroxy corticosteroids responses to metyrapone in normal subjects.
    Jubiz W; Frailey J; Tyler FH
    Clin Chem; 1970 Apr; 16(4):352-3. PubMed ID: 4315142
    [No Abstract]   [Full Text] [Related]  

  • 16. [Glyco-active adrenocortical function in the elderly. Dynamic tests using metopirone, dexamethasone and bacterial pyrogen].
    Lenzi S; Abate G; Bernardi P; Montini T
    Ann Endocrinol (Paris); 1968; 29(3):301-12. PubMed ID: 4326386
    [No Abstract]   [Full Text] [Related]  

  • 17. [New practical methods for clinical assessment of adrenal cortex function. Experience with a gas chromatography method for the quantitative determination of free C21-17-hydroxycorticosteroids in plasma and urine].
    Gerdes H; Teller W
    Acta Endocrinol (Copenh); 1968 Oct; 59(2):203-17. PubMed ID: 4301812
    [No Abstract]   [Full Text] [Related]  

  • 18. [Anterior pituitary gland insufficiency in sarcoidosis].
    Weber A; Behrend H; Gerdes H
    Dtsch Med Wochenschr; 1968 Jul; 93(30):1427-32 passim. PubMed ID: 4299248
    [No Abstract]   [Full Text] [Related]  

  • 19. Disturbance of pituitary-adrenal interrelationships in benign intracranial hypertension (pseudotumor cerebri).
    Oldstone MB
    J Clin Endocrinol Metab; 1966 Dec; 26(12):1366-9. PubMed ID: 4289594
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical studies on the adrenocorticotropic hormone. II. Studies on the mechanism of pituitary corticotropin secretion with synthetic lysine vasopressin].
    Mayama T
    Nihon Naibunpi Gakkai Zasshi; 1968 Jan; 43(10):947-56. PubMed ID: 4298936
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.